The processes that control genome stability are essential for the development of the Central Nervous System (CNS) and the prevention of neurological disease.
Introduction
Mutations affecting DNA damage response factors are associated with neurodegenerative disease in humans. For example, inactivation of the DNA damage kinase ATM (Ataxia telangiectasia mutated) is associated with ataxia (for review see (Shiloh and Ziv, 2013) ). Similarly, mutations in the ATR (ATM and Rad3-related) kinase are the cause of Seckel syndrome, a disease characterized by microcephaly and mental retardation (O'Driscoll et al., 2003) . ATM and ATR are activated in response to DNA lesions and orchestrate cell cycle arrest, activation of DNA repair, and apoptosis. These kinases are activated by different type of lesions with ATR induced by single-stranded DNA while ATM is activated by DNA double-strand breaks (DSBs) (Cimprich and Cortez, 2008; Shiloh and Ziv, 2013) .
Telomeres are essential nucleoprotein structures that protect chromosome ends from being recognized as sites of DNA lesions. In mammals, suppression of the DNA damage response at chromosome ends is achieved by the recruitment of a specialized protein complex termed shelterin that binds the telomeric DNA repeats (TTAGGGn) (for review, see (de Lange, 2009) ). Telomeric repeats are lost upon cellular division leading to progressive telomeric shortening with age. When telomeres become critically short, they fail to recruit sufficient shelterin complex.
Dysfunctional telomeres are recognized as sites of DNA damage leading to aberrant DNA repair and activation of the tumor protein p53 which in turn depending on the cellular context can trigger apoptosis or senescence (for review see (Denchi, 2009) ). The current model for the mechanism of POT1 mediated suppression of ATR signaling involves the ability of POT1 to bind the singlestranded portion of telomeric DNA (Denchi and de Lange, 2007a; Gong and de Lange, 2010) . When POT1 is depleted, the single stranded binding protein RPA localizes to the telomeric g-overhang leading to ATR activation. In contrast, the model for TRF2-mediated suppression of ATM involves the formation of a protective secondary structure called T-loop that sequester the ends of a chromosome, thereby preventing its recognition as a double-stranded break (DSB) (Doksani et al., 2013; Griffith et al., 1999) . In addition, TRF2 is able to actively suppress localization of the DNA damage factor RNF168 thus suppressing the activation of a DNA damage response downstream of ATM activation (Okamoto et al., 2013) .
In humans, there are a number of syndromes characterized by short telomeres that collectively are referred to as telomere biology disorders (TBDs) (for review see (Savage, 2014) ) which include Dyskeratosis congenita (DC), Hoyeraal-Hreidarsson syndrome and Coats plus syndrome. These complex diseases range in clinical severity, from DC, which involves multiple organs, to diseases with only one organ affected, such as pulmonary fibrosis. In these patients, the most affected tissues tend to be those with high turnover, like the hematopoietic system. This is consistent with the notion that telomere erosion occurs more rapidly in these tissues. However, defects in organs such as the brain, which is not characterized by a high turnover rate, are also observed in these patients. For instance, patients affected the Hoyeraal-Hreidarsson syndrome show severe cerebellar hypoplasia and microcephaly (Hoyeraal et al., 1970) .
Moreover, a significant fraction of Dyskeratosis congenita patients have cognitive defects (Rackley et al., 2012) . These observations suggest that telomere dysfunction could affect brain development or proper neurological function.
Additionally, late generation telomerase knockout mice display defects in tissues with a high rate of turnover as well as neurological impairment and cognitive defects (Ferron et al., 2004) . Furthermore, telomerase reactivation in mice with short telomeres results in telomere elongation and the alleviation of neurological impairments (Jaskelioff et al., 2011; Tomas-Loba et al., 2008) . Thus, it is anticipated that upon critical telomere shortening, the initiation of a DNA damage response at chromosome ends would lead to either cell death or impairment in neurological function. This was confirmed by the observation that depletion of the shelterin component TRF2 in the developing mouse brain leads to severe perturbation in neurogenesis and causes cognitive defects (Lobanova et al.) .
Notably, TRF2 depletion in nestin-positive progenitor cells causes the death of the vast majority of neuronal cells and results in embryonic lethality (Lobanova et al.) .
In contrast, telomere dysfunction induced by depletion of the shelterin component POT1a has a mild effect on brain development and does not result in embryonic lethality (Lee et al., 2014) . Moreover, POT1a depletion is well tolerated in the vast majority of neuronal cells and only affects a subset of neurons in the cerebellum (Lee et al., 2014) . It is currently unclear why there is such a difference in the phenotypes induced by depletion of TRF2 and POT1a. A major difference between the telomere dysfunction induced by TRF2 depletion and POT1a depletion is the level of end-to-end chromosome fusions induced.
Notably, two distinct conditional knockout mice for POT1a have been generated, one in which the first coding exon is depleted following Cre expression (Wu et al., 2006) . In this setting, an alternative start site generates a truncated protein which is predicted to localize at telomeres (for more details see (Hockemeyer et al., 2006) ). This mouse was used to probe the consequences of POT1a depletion during neuronal development (Wu et al., 2006) . A different POT1a conditional knockout mouse was generated by the de Lange laboratory in which the third coding exon can be depleted generating truncation products that cannot localize to telomeres (Hockemeyer et al., 2006) . We have previously used this conditional knockout mouse to test the role of POT1a depletion in the lymphoid compartment (Pinzaru et al., 2016) . Here, we investigated whether depletion of POT1a using this mouse model results in similar phenotypes as the ones previously reported (Lee et al., 2014) . Our data confirm that conditional depletion of POT1a in the developing mouse brain affects primarily the cerebellum, a phenotype that can be fully rescued by p53 inactivation. Strikingly however, our results indicate that POT1a depletion using the POT1a allele generated by the de Lange laboratory (Hockemeyer et al., 2006 ) has a more penetrant and severe phenotype compared to what reported using the other available POT1a conditional knock out mouse model (Wu et al., 2006) . Collectively, this data reveals that different levels of telomere dysfunction can give rise to profoundly different outcomes in the developing brain.
Material and methods

Mice
The Pot1a and p53 conditional alleles have been previously described (Celli and de Lange, 2005; Hockemeyer et al., 2006; Marino et al., 2000) . To achieve inactivation of the POT1a and p53 in the nervous system Nestin-Cre mice (Marino et al., 2000) 
Histology
Histology procedures were performed as previously described ) (Lobanova et al.) . Brains were collected at indicated time points and fixed by perfusion with 4% buffered PFA. All samples were paraffin-embedded and sectioned by a microtome (4μm). Sections were stained with Gill modified hematoxylin (Harleco) and eosin Y (Ricca Chemicals) to detect morphological differences. For IHC, paraffin-embedded sections were treated for 20 minutes in boiling EDTA buffer for antigen retrieval. DNA damage response activation and apoptosis detection was performed by the antibodies anti-phospho-H2AX (mouse, 1:3000, Millipore) and anti-Casp3 (rabbit, 1:1000, Cell Signaling). An antidoublecortin antibody (rabbit, 1:3000, abcam) was used to label neuronal progenitors. Detection was performed using the ImmPRESS HRP Polymer Detection Kit (Vector Labs) and the Metal Enhanced DAB Substrate Kit (Thermo Scientific) according to the manufacturer's instructions. Each staining was performed on at least three samples of each genotype. All slides were examined and imaged using an Axio Imager M1 microscope (Zeiss).
Results
POT1a depletion in neural progenitor cells leads to ataxia
The mouse genome encodes for two POT1 orthologs: POT1a and POT1b (Hockemeyer et al., 2006; Wu et al., 2006) . POT1a is involved in protection of chromosome ends from the DNA damage response pathway, while POT1b
regulates the amount of single-stranded DNA at the telomere terminus (Hockemeyer et al., 2006 Fig   1d) and histological examination revealed a striking reduction in the development of the cerebellum and of the dentate gyrus (Fig 1d) . The severe cerebellar hypoplasia observed in Pot1a F/F,Nes mice explains the lack of motor skills in these animals and is reminiscent of other mouse models with increased levels of DNA damage in the developing brain, such as ATR and TOPBP1 conditional knockout mice (Lee et al., 2009; Lee et al., 2012) . These results are in line with the induction of a DNA damage response following POT1a depletion (Denchi and de Lange, 2007b; Gong and de Lange, 2010; Guo et al., 2007) and suggests that during embryogenesis the cerebellum is particularly susceptible to DNA damage induction.
Phenotypes associated with Pot1a depletion in neural progenitor can be rescued by p53 inactivation.
The DNA damage response pathway results in p53 activation and, in turn, apoptosis is induced. Therefore, we decided to test whether the lethality and neuronal degeneration in Pot1a F/F,Nes mice was caused by p53 activation. To this end, we crossed Pot1a F/F,Nes mice with mice carrying a conditional p53 allele (Marino et al., 2000) . The resulting Pot1a F/F p53 F/F,Nes mice were born at the expected mendelian ratio, were viable, and appeared morphologically indistinguishable from control mice (Fig 2a-c) . We followed a cohort of Pot1a F/F p53 F/F,Nes mice and relative control mice for 10 months and observed no evidence of increased malignancy associated with concomitant inactivation of POT1a and p53 in the CNS (Fig 2a) . In contrast, depletion of POT1a in animals heterozygous for p53 (Pot1a F/F p53 F/+,Nes ) leads to a phenotype that was indistinguishable from the depletion of POT1a from p53 wild type animals (Fig 2a-c) . Next, we assessed whether p53 inactivation suppressed the developmental defects observed in the Pot1a F/F,Nes mice. We found that Pot1a F/F p53 F/F,Nes mice had the same size brain as POT1a proficient mice (Fig 3a) . In addition, p53
inactivation was sufficient to restore the proper morphology and size of the cerebellum (Fig 3b) and of the dentate gyrus (Fig 3c) . In accordance with this,
Pot1a
F/F p53 F/F,Nes mice displayed no signs of ataxia (Fig 2b) . Moreover, p53
inactivation suppressed the loss of DCX-positive progenitor cells that is characteristic of Pot1a F/F,Nes mice (Fig 3c) . This data shows that upon POT1a depletion, p53 induction-rather than telomere dysfunction-causes embryonic lethality and neuronal degeneration. Next, we tested whether the lethality associated with TRF2 depletion in nestin-positive cells (Lobanova et al.) was caused by p53 induction. Our data shows that p53 inactivation was not sufficient to rescue the lethality associated with TRF2 inactivation (Fig 2e) . This data further highlights the difference between consequences of POT1 and TRF2 depletion in neural progenitor cells.
Discussion
Acute telomere dysfunction affects neurogenesis
In the context of highly proliferative tissues, telomere dysfunction arising from critical shortening of telomere repeats has been established has a major factor limiting regeneration potential and, in some cases, as a driver for genomic instability. Less is known on the potential role of telomere dysfunction in organs that do not undergo high levels of turnover. Some lines of evidence suggested that critically short telomeres may cause neurological defects in human pathologies, but the incomplete penetrance of neurological phenotypes in telomere biology disorders (TBDs) raised the possibility that telomere dysfunction by itself may not be sufficient to cause these phenotypes. Mouse models lacking telomerase have been well characterized and demonstrated that animals with critically short telomeres have neurological associated defects, such as decreased sense of smell and cognitive defects (Rackley et al., 2012) . However, in these mouse models, telomere dysfunction is not restricted to the CNS, thus there is the possibility that systemic factors might contribute to these phenotypes. Recently, conditional depletion of shelterin factors has been used to define the consequences of telomere dysfunction in the CNS (Lee et al., 2014) (Lobanova et al.) . In these models, deletion of POT1a or TRF2 are restricted to the CNS using the neuronal specific Cre lines Nestin-Cre; Nex-CRE and Dcx-CRE. The results of these studies revealed a striking difference in the phenotype triggered by POT1a depletion and TRF2 depletion. Indeed, while depletion of POT1a using the Nestin-CRE line resulted in limited neurodegeneration, TRF2 depletion in the same cell types produce massive neurodegeneration and resulted in embryonic lethality. Here, we used a different mouse strain than the one previously reported to conditionally importantly share the same fundamental properties. In both cases, the only affected area is the cerebellum, and in both cases, p53 inactivation fully rescues the observed degeneration. Observed differences are unlikely to be caused by differences in genetic background since in both studies mice were in a Bl6 background. Additionally, both studies used the same CRE driver line, excluding possible differences in the efficiency of CRE-mediated depletion. The major contributing difference is related to the conditional POT1a knockout mouse strain used. The McKinnon laboratory used a conditional knockout mouse model in which the first coding exon of POT1a is depleted following Cre expression (Wu et al., 2006) . In this setting, an N-terminally truncated POT1a protein lacking about one third of the first OB-fold can be generated using an alternative ATG on the second coding exon (see for complete detail the supplemental information in (Hockemeyer et al., 2006) ). This protein is predicted to localize at telomeres through the interaction with the telomere associated protein TPP1. In contrast, we used a conditional KO mouse in which, upon CRE expression, the third coding exon is depleted, leading to the formation of a small C-terminally truncated POT1a allele that cannot localize to telomeres and it is therefore fully not functional (Hockemeyer et al., 2006) .
p53 -dependent and -independent neuronal loss upon telomere dysfunction
A striking finding in our study was the effect of p53 inactivation on the consequences of telomere dysfunction. Firstly, we found that p53 inactivation could fully rescue the phenotype of POT1a depletion in the CNS. This finding shows that the lethality associated with POT1a depletion in neuronal progenitors is caused by activation of a DNA damage response that triggers p53 activation.
Strikingly, this data shows that once the p53 response is abrogated, telomere dysfunction initiated by POT1a depletion can be well tolerated in the CNS. TRF2-depletion, which has been shown to display a more severe phenotype, could not be rescued by p53 inactivation. There are two main differences between POT1a and TRF2 depletion that could explain the differential p53-dependent response: i)
TRF2 depletion leads to frequent end-to-end chromosome fusions (Celli and de Lange, 2005; Denchi and de Lange, 2007a; Doksani et al., 2013; Karlseder et al., 1999; Lazzerini Denchi et al., 2006) that could affect the division or differentiation of neuronal progenitor cells. In contrast POT1a depletion leads only to modest levels of telomere fusions (Denchi and de lange, 2007c; Gong and de Lange, 2010; Hockemeyer et al., 2006; Hockemeyer et al., 2005; Wu et al., 2006) , which could be well tolerated in the CNS. ii) TRF2 depletion triggers an ATM-dependent DNA damage response while POT1a depletion triggers an ATR-dependent DNA damage response (Denchi and de Lange, 2007a) . It is therefore possible that activation of these kinases might lead to differences in phenotypes arising from telomere dysfunction. However, this seems unlikely given the established interconnection between these two signaling pathway. Indeed, work by the
McKinnon lab established that in the CNS, POT1a depletion leads to ATR activation that sequentially triggers ATM activation. Based on this data, we favor the hypothesis that the level of telomere fusions determines the outcome of telomere dysfunction in the developing brain.
Telomere dysfunction and neurological defects
Our data indicates that the level of telomere dysfunction dictates the degree of neuronal loss in the developing brain. The microcephaly and cerebellar hypoplasia observed in Pot1a F/F,Nes mice resemble the phenotypes observed in patients affected with the Hoyeraal-Hreidarsson syndrome (Hoyeraal et al., 1970) .
This data suggests that these patients suffer from telomere dysfunction occurring in neuronal progenitors, likely causing the observed brain development defects. In contrast, patients with other telomere biology disorders such as DC patients show either no neurological defect or less severe phenotypes (Rackley et al., 2012) . It is conceivable that neuronal progenitors of DC patients have sufficiently long telomeres to maintain telomere protection and ensure a brain development.
Nevertheless, some DC patients do display some cognitive defects (Rackley et al., 2012) , suggesting that telomere dysfunction arising in more differentiated cell types or during adult neurogenesis could affect the proper neuronal function.
Future experiments employing conditional TRF2 and POT1a depletion in differentiated neurons will be required to test the role of telomere dysfunction in these cell types.
Finally, the finding that microcephaly and cerebellar hypoplasia of 
